Autobio(SH:603658)2023-11-01 01:42Group 1: Market Overview - The main export products of Antu Bio are fully automated chemiluminescence immunoassay analyzers and fully automated microbial mass spectrometry detection systems, with different sales performance across regions [1] - The chemiluminescence business is primarily distributed in the Asia-Pacific region, while the microbiology business is focused on Europe and the international market [1] - Antu Bio expects its overseas business to maintain rapid growth over the next 3-5 years [1] Group 2: Policy Impact - The implementation of the chemiluminescence centralized procurement policy is expected to positively impact the market structure and the development of the in vitro diagnostic industry [1] - The introduction of the Jiangxi biochemical centralized procurement policy will also have a positive effect on industry development, with the company's biochemical immunology production line driving future growth [2] Group 3: Financial Performance - The company's gross profit margin has been rising quarter by quarter, primarily due to changes in product structure and an increased contribution from self-produced products [2] - The research and development expense ratio is expected to decrease in the fourth quarter, with a normal level anticipated for the following year [2]